VELIN-PHARMA A/S: Financial statements 2025
CVR: 33026013
Source: annual report 2025, Danish Business Authority
01/06/2024 – 31/05/2025
VELIN-PHARMA A/S (CVR 33026013) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658. The solvency ratio was 91%.
- Gross Profit
- DKK 94,968
- Profit/Loss
- DKK -16,021,366
- Equity
- DKK 33,462,658
- Total Assets
- DKK 36,756,565
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | 95K | -16M | 33.5M | 0 |
| 2024 | - | -3K | 12.7M | 49.5M | 0 |
| 2023 | - | 161K | 5.5M | 36.8M | 0 |
| 2022 | - | 440K | 3.1M | 31.2M | 0 |
| 2021 | - | 150K | 6M | 28.1M | 0 |
Official annual report
How creditworthy is VELIN-PHARMA A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreAbout VELIN-PHARMA A/S
VELIN-PHARMA A/S is a Danish company of the type Aktieselskab based in Fredensborg, founded in 1971. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named JOHANNES LARSENS EFTF.. V. OG F VELIN A/S and JOHANNES LARSENS EFTF., V. OG F. V ELIN A/S. The management consists of Flemming Velin. The board consists of Thomas Velin (chair), Flemming Velin and Majken Velin. The company's owners include Flemming Velin, Majken Velin and Thomas Velin. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 94,968 and a net result of DKK -16,021,366 compared with DKK 12,695,295 the year before. Equity in the 2025 report amounted to DKK 33,462,658.